Work

Assessing Heterogeneity of Treatment Effects from Canagliflozin (CANA) on Kidney Outcomes Using the Joslin Kidney Panel: Insights from the CREDENCE Trial

Year: 2024

Type: article

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.2024xdy3htkd

Authors: Sok Cin Tye, Zaipul Md Dom, Eiichiro Satake, Michael K. Hansen, Matthew Douglas Breyer, Andrzej S. Krolewski

Institutions: Joslin Diabetes Center, Harvard University, Janssen Research & Development (United States)

Language: English

Topic: Chronic Kidney Disease and Diabetes

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403811341

FWCI:

Cites:

Cited by:

Related to: 10